Cause of Resistance to Tumor Immunotherapy
(University of Zurich, July 25, 2017)
In tumor immunotherapy, the body’s own defense system is activated against the tumor cells. However, for the majority of patients, the tumor cells become resistant to the treatments used. Researchers at the University of Zurich and the University Hospital Zurich have now found in skin cutaneous melanoma that an epigenetic control protein is key to the development of this resistance.